Chiropractic Therapy Offers Long Term Benefits for Fibromyalgia Sufferers

If you suffer with fibromyalgia, you are not alone, as Drs. Matt & Annie Reyes sees many patients with this particular condition in our State College chiropractic practice. As a matter of fact, the Centers for Disease Control and Prevention (CDC) reports that roughly two percent of all adults in the USA have fibromyalgia issues. Luckily, chiropractic therapy is one treatment option that can provide positive results.

Research Shows Chiropractic Care Helps Fibromyalgia Discomfort

In a study released in mid-2015, 215 adults with fibromyalgia were evaluated based on factors ranging from pain to quality of sleep to the levels of depression or anxiety they felt. Then they were divided into two groups with one group receiving a multi-modal treatment plan for three months and the second group receiving the same program plus chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The individuals who received chiropractic adjustments in addition to the multi-disciplinary treatment approach reported greater results in all areas (pain, sleep, depression, and anxiety) at 12 weeks post-treatment when compared to the study people who received multi-modal therapy without chiropractic treatment. Furthermore, those positive results were long-lasting as the subjects reported continued improvement one full year later.

Fibromyalgia issues can greatly reduce your quality of life, both mentally and physically. If you're suffering from fibromyalgia, we might be able to help.

You don't have to suffer! To find out what Drs. Matt & Annie Reyes can do for your fibromyalgia pain, call our State College chiropractic office today.

Studies

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.